{"doi":"10.1017/ash.2022.29","title":"Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system","abstract":"Abstract\n\t We performed severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antinucleocapsid IgG testing on 5,557 healthcare providers and found a seroprevalence of 3.9%. African Americans were more likely to test positive than Whites, and HCWs with household exposure and those working on COVID-19 cohorting units were more likely to test positive than their peers.","journal":"Antimicrobial Stewardship & Healthcare Epidemiology","year":2022,"id":645467,"datarank":0.16479184330021646,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.0,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":80022,"name":"Xiaochun Zhang","orcid":"0000-0002-9816-1034","position":1,"is_corresponding":false},{"id":1680739,"name":"Jaime H Noguez","orcid":"0000-0003-1358-9005","position":2,"is_corresponding":false},{"id":800947,"name":"Lisa M. Stempak","orcid":"0000-0001-8314-7638","position":3,"is_corresponding":false},{"id":1209748,"name":"Daniel J. Tisch","orcid":"0000-0001-7315-2839","position":4,"is_corresponding":false},{"id":800949,"name":"Christine Schmotzer","orcid":"0000-0002-7235-8728","position":5,"is_corresponding":false},{"id":281106,"name":"Robert A. Salata","orcid":"0000-0001-8464-0918","position":6,"is_corresponding":false},{"id":731474,"name":"Elie Saade","orcid":"0000-0002-2514-3820","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system","abstract":"Abstract\n\t We performed severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antinucleocapsid IgG testing on 5,557 healthcare providers and found a seroprevalence of 3.9%. African Americans were more likely to test positive than Whites, and HCWs with household exposure and those working on COVID-19 cohorting units were more likely to test positive than their peers.","is_dataset_classified":null,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"36310795","pmcid":"PMC9614926","openalex_id":"https://openalex.org/W4293204275","authors":[],"funders":[],"total_grants":0,"fwci":0.1932,"citation_percentile":0.4861389,"influential_citations":0,"citation_trend":[{"year":2023,"count":1},{"year":2024,"count":1}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/1DBE4C24C275456F94A2C35B9C8E6EB6/S2732494X22000298a.pdf/div-class-title-seroprevalence-of-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2-among-healthcare-providers-prior-to-the-vaccine-era-in-an-integrated-midwestern-healthcare-system-div.pdf","host_type":"journal"},{"url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/1DBE4C24C275456F94A2C35B9C8E6EB6/S2732494X22000298a.pdf/div-class-title-seroprevalence-of-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2-among-healthcare-providers-prior-to-the-vaccine-era-in-an-integrated-midwestern-healthcare-system-div.pdf","host_type":"publisher"},{"url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S2732494X22000298","host_type":"publisher"},{"url":"https://doi.org/10.1017/ash.2022.29","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/36310795","host_type":"repository"},{"url":"https://commons.case.edu/facultyworks/124","host_type":""},{"url":"https://doaj.org/article/5d6839f1b316482aa01a72d140e769f3","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9614926","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC9614926","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC9614926?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["SARS-CoV-2 and COVID-19 Research","COVID-19 epidemiological studies","Vaccine Coverage and Hesitancy"],"mesh_terms":[],"keywords":["Seroprevalence","Health care","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Medicine","Coronavirus disease 2019 (COVID-19)","Coronavirus","Healthcare system","2019-20 coronavirus outbreak","Respiratory system","Severe acute respiratory syndrome coronavirus","Virology","Internal medicine","Immunology","Antibody","Disease","Outbreak","Infectious disease (medical specialty)","Serology","Political science"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-09T06:07:21.966380Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}